“…The potential utility of this strategy is supported by clinical case reports that have documented M. bovis disease in HIV type 1 (HIV-1)-infected humans who have been vaccinated with M. bovis BCG (2,5,27,28,34). Moreover, M. bovis infection in humans can induce a zoonotic tuberculosis that is indistinguishable from that caused by M. tuberculosis in terms of pathogenesis, lesions, and clinical findings (3,8,24,30).…”